AAM
TNDM icon

Azzad Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Azzad Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,508
Closed -$814K – 316
2020
Q4 		$814K Buy
+8,508
New +$877K 0.15% 210

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Azzad Asset Management's TNDM Position: Q1 2021 in Review

Azzad Asset Management sold out of Tandem Diabetes Care (TNDM) in Q1 2021, closing a stake of 8,508 shares — an estimated $814K sold.

Azzad Asset Management first reported a position in TNDM in Q4 2020 and held it in 1 quarter. The position peaked at $814K in Q4 2020. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

  • Azzad Asset Management reported no remaining Tandem Diabetes Care position as of Q1 2021 after selling out during the quarter.
  • Azzad Asset Management sold 8,508 Tandem Diabetes Care shares in Q1 2021, an estimated $814K.
  • Azzad Asset Management first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 1 quarter.
  • Azzad Asset Management's Tandem Diabetes Care position peaked at $814K in Q4 2020.
  • 290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on Azzad Asset Management's 13F filing for Q1 2021, filed 1 Apr 2024.